Fagron NV(FAGR.BR)— 技術面狀態
數據截至2026-09-21 — 每個交易日晚間對全部追蹤範圍重新計算。Closelook研究日記,不構成投資建議。
Trades -2.6% vs the 50-day and -2.8% vs the 200-day average, 13.2% below the 52-week high and +14.9% off the 52-week low; a death cross printed 1 sessions ago. Computed from daily closes.
Ranked #4 on today’s Directional Flow — fresh crosses list (scan of 2026-09-21).
移動平均線狀態
- 相對20日均線+0.3%
- 相對50日均線-2.6%
- 相對200日均線-2.8%
- 52週區間低於52週高點13.2% · 高於52週低點14.9%
- 均線交叉死亡交叉(1個交易日前)
- 50日均線交叉股價向下穿越50日均線(47個交易日前)
- 隨機指標%K 71 · %D 73.2(死亡交叉)
相關頁面: FAGR.BR圖表與概覽 · 品質與財務體檢 · 訊號看板
FAQ · from the current data · as of 2026-09-21
Quick answers
FAGR.BR目前的Closelook訊號是什麼?
Mixed moving-average stack — Trades -2.6% vs the 50-day and -2.8% vs the 200-day average, 13.2% below the 52-week high and +14.9% off the 52-week low; a death cross printed 1 sessions ago. Computed from daily closes.(截至2026-09-21;訊號看板每個交易日晚間對全部追蹤範圍重新計算。研究日記讀數,不構成投資建議。)
FAGR.BR目前是否位於50日與200日均線上方?
截至2026-09-21,Fagron NV位於50日均線下方(-2.6%),200日均線下方(-2.8%);距20日均線+0.3%。
FAGR.BR距52週高點有多遠?
截至2026-09-21,低於52週高點13.2%,高於52週低點14.9%。
Related in the Closelook universe
then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- LNTH Lantheus Holdings Incindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- AMRX Amneal Pharmaceuticals, Inc. Class A Common Stockindustry
- BHC.TO Bausch Health Companies Incindustry
- ALKS Alkermes Plcindustry
- HCM.L HUTCHMED China Ltdindustry
- PRGO Perrigo Company PLCindustry
- VTRS Viatris Incindustry
- RDY Dr. Reddy’s Laboratories Ltd ADRindustry
- DMP.DE Dermapharm Holding SEindustry
- UTHR United Therapeutics Corporationindustry
- ZTS Zoetis Incindustry
- GALDY GALDERMA GROUP AGindustry
- ELAN Elanco Animal Healthindustry
- NBIX Neurocrine Biosciences Incindustry
- ARGX.BR Argen-Xsector
- UCB.BR UCB SAsector
- TUB.BR Tubize-Finsector
- BION.SW BB Biotech AGsector